New imaging technique to improve treatment for liver cancer
Novel PET Imaging to Guide Therapy in Hepatocellular Carcinoma
This study is testing a new imaging method to help doctors see how well treatments are working for patients with liver cancer, so they can make faster and better decisions about their care.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Tx Md Anderson Can Ctr NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-10980028 on NIH RePORTER |
What this research studies
This research focuses on developing a novel PET imaging method to better predict how patients with hepatocellular carcinoma (HCC) respond to locoregional therapies like Yttrium-90 radioembolization. By using advanced imaging technology, the goal is to provide quicker and more accurate assessments of treatment effectiveness compared to traditional imaging methods. This could significantly reduce the waiting time for patients and help guide their ongoing treatment decisions. The study aims to evaluate the effectiveness of this imaging approach in detecting cancer cell activity and response to therapy.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with hepatocellular carcinoma who are undergoing locoregional therapies.
Not a fit: Patients with liver cancer who are not eligible for locoregional therapies or those with other types of cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to faster and more reliable treatment decisions for patients with liver cancer.
How similar studies have performed: Previous research has shown promising results with similar imaging techniques in cancer treatment, indicating potential for success in this novel approach.
Where this research is happening
Houston, United States
- University of Tx Md Anderson Can Ctr — Houston, United States (Active)
Researchers
- Principal investigator: Manning, Henry Charles — University of Tx Md Anderson Can Ctr
- Study coordinator: Manning, Henry Charles
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.